On the RVX Hub, SanFran wrote: "I'm glad we have a Webcast coming up for Resverlogix. But it is Zenith that we really need an update from. More than Resverlogix. Among other things, whatever happened to the re-org???"
I agree. We need an update. We are now over 4 months past the original anticipated closing date of February 1, 2016 for the Zenith re-organization. Zenith communicated that the initial delay of the closing was because they first wanted to get the clinical trial started without delay. 4 of 7 sites are now listed as recruiting according to ClinicalTrials.gov. What is the status of the trial? Has dosing started?
Zenith is attending (not presenting) the American Society for Clinical Oncology meeting that runs from June 3 to June 7. And then BIO International runs June 6 to June 9. But after that no more Q2 events on the Zenith schedule.....so I really hope and expect them to provide an update sometime in June before the end of Q2.
BearDownAZ
